Nouveau Life Offers Potential Distributors Online Access to Company and Contract
FORT LAUDERDALE, Fla., Aug. 9, 2012 /PRNewswire/ — Nouveau Life Pharmaceuticals, Inc. (Pink Sheets: NOUV), a provider of quality all-natural dietary supplements, now offers distribution firms an online channel to express their interest in a partnership.
Nouveau Life’s website now includes a page dedicated to product distributors. The page contains a form for mass distribution firms to express their interest in partnering with Nouveau Life. A key component of this form is its delivery route – distributor page form submissions are sent directly to Nouveau Life CEO Melissa Walker.
“Distribution partnerships are a critical component in the success of consumer goods companies. I do not want to take the chance of missing an opportunity because an email wasn’t forwarded, so I had the web developer route the distributor form submissions directly to my inbox,” stated Walker.
Another highlight of the new distributor webpage is the inclusion of a full Nouveau Life Mass Distributor Contract. Allowing upfront access to the contract provides mass distribution firms the ability to assess a possible partnership without the need for an extensive investment of time and it inhibits less-than-serious inquiries. The downloadable contract is complete with the exception of the discount afforded each distributor as this will be negotiated on a per company basis.
For more information or to view the distributor webpage, visit www.nlpnaturals.com/distributor.
About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
Forward-Looking Statements – This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.
Nouveau Life Pharmaceuticals, Inc. – 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.